NCT01922349 - Safety, Tolerability and Pharmacokinetics of BI 113608 in Healthy Asian and Caucasian Male Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Healthy

Interventions

DRUG

BI 113608

Medium dose (Multiple dosing)

DRUG

Placebo

Placebo (Multiple dosing)

DRUG

BI 113608

Low dose (Multiple dosing)

DRUG

Placebo

Placebo (Single dosing)

DRUG

BI 113608

High dose (Single dosing)

DRUG

BI 113608

Medium dose (Single dosing)

DRUG

BI 113608

Low dose (Single dosing)

DRUG

BI 113608

High dose (Multiple dosing)

Trial Locations (1)

1314.9.8201 Boehringer Ingelheim Investigational Site, Seoul